Showing 761 - 780 results of 933 for search '"virology"', query time: 0.06s Refine Results
  1. 761
  2. 762
  3. 763
  4. 764
  5. 765
  6. 766
  7. 767
  8. 768
  9. 769
  10. 770
  11. 771
  12. 772
  13. 773

    Evaluating Adherence to Antiretroviral Therapy Using Pharmacy Refill Records in a Rural Treatment Site in South Africa by George Gachara, Lufuno G. Mavhandu, Elizabeth T. Rogawski, Cecile Manhaeve, Pascal O. Bessong

    Published 2017-01-01
    “…Logistic regression was also performed to determine the relationship between adherence and virologic suppression and the adherence threshold resulting in <10% virologic failure. …”
    Get full text
    Article
  14. 774

    Long-Term Outcome of an HIV-Treatment Programme in Rural Africa: Viral Suppression despite Early Mortality by Roos E. Barth, Hugo A. Tempelman, Robert Moraba, Andy I. M. Hoepelman

    Published 2011-01-01
    “…To define the long-term (2–4 years) clinical and virological outcome of an antiretroviral treatment (ART) programme in rural South Africa. …”
    Get full text
    Article
  15. 775

    Comparison of Expectant and Excisional/Ablative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in the Era of HPV Testing by Kevin Dominique Tjandraprawira, Adeola Olaitan, Aviva Petrie, Nafisa Wilkinson, Adam N. Rosenthal

    Published 2022-01-01
    “…Among 175 (52.9%) patients initially managed conservatively, 77.3% (133/172) regressed, 13.4% (23/172) persisted, 9.3% (16/172) progressed to CIN3+, and 97 (56.4%) patients achieved virological regression. 156 (47.1%) patients underwent initial excision/ablation, with an 89.4% (110/123) virological cure rate. …”
    Get full text
    Article
  16. 776
  17. 777

    Restoration of Innate and Adaptive Immune Responses by HCV Viral Inhibition with an Induction Approach Using Natural Interferon-Beta in Chronic Hepatitis C by Y. Kishida, N. Imaizumi, H. Tanimura, Y. Haruna, S. Kashiwamura, T. Kashiwagi

    Published 2012-01-01
    “…IL-15 was increased at the end of induction therapy in both early virologic responders (EAVRs) and late virologic responders (LAVRs); CXCL-8, CXCL-10, and CCL-4 levels were significantly decreased (𝑃<0.05) in EAVR but not in LAVR during NCT, and IL-12 increased significantly (𝑃<0.05) and CXCL-8 decreased significantly (𝑃<0.05) after the end of NCT in EAVR but not in LAVR. …”
    Get full text
    Article
  18. 778
  19. 779
  20. 780